KO

KOREAN DRUG CO., LTD.

Develops, manufactures, and markets pharmaceuticals and other healthcare products.

014570 | KO

Overview

Corporate Details

ISIN(s):
KR7014570006
LEI:
Country:
South Korea
Address:
경기도 이천시 신둔면 원적로 69-10, 이천시

Description

Korean Drug Co., Ltd. is a pharmaceutical company engaged in the development, manufacturing, and marketing of a diverse range of healthcare products. The company's portfolio includes over-the-counter (OTC) and prescription (ETC) medicines, health supplements, cosmetics, and medical devices. It aims to provide comprehensive health solutions. The company is also active in research and development, maintaining a drug pipeline and conducting clinical trials in various therapeutic areas, including treatments for the nervous system.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
반기보고서 (2025.06)
Korean 1.1 MB
2025-08-13 00:00
자기주식처분결과보고서
Korean 16.2 KB
2025-08-11 00:00
주요사항보고서(자기주식처분결정)
Korean 28.5 KB
2025-07-02 00:00
자기주식처분결과보고서
Korean 16.3 KB
2025-06-30 00:00
주요사항보고서(자기주식처분결정)
Korean 28.6 KB
2025-06-05 00:00
자기주식처분결과보고서
Korean 16.3 KB
2025-06-02 00:00
주요사항보고서(자기주식처분결정)
Korean 28.6 KB
2025-05-15 00:00
분기보고서 (2025.03)
Korean 1019.2 KB
2025-03-21 00:00
정기주주총회결과
Korean 23.7 KB
2025-03-21 00:00
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 12.6 KB
2025-03-13 00:00
감사보고서제출
Korean 18.4 KB
2025-03-13 00:00
사업보고서 (2024.12)
Korean 444.5 KB
2025-03-06 00:00
자기주식처분결과보고서
Korean 16.3 KB
2025-03-04 00:00
주요사항보고서(자기주식처분결정)
Korean 28.5 KB
2025-02-26 00:00
주주총회소집공고
Korean 102.6 KB

Automate Your Workflow. Get a real-time feed of all KOREAN DRUG CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for KOREAN DRUG CO., LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for KOREAN DRUG CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.